Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Lurasidone (Latuda) commonly causes restlessness or an urgent need to move called akathisia, along with drowsiness, nausea, and movement-related effects that often appear early in treatment or after a dose increase. It must be taken with a meal of at least 350 calories, because taking it on an empty stomach can cut absorption roughly in half and reduce its effectiveness, and grapefruit and certain antibiotics or antifungals can raise drug levels. Ongoing monitoring typically includes weight, blood sugar, cholesterol, blood pressure, mood changes, and signs of abnormal movements, since some risks build quietly over months. There are several important factors to consider, including which symptoms warrant urgent care and which tend to fade, so see below to understand more. If you are feeling restless, sedated, or simply unsure whether what you are experiencing is a side effect or something else, a free, instant, online symptom check can help you organize your symptoms, gauge urgency, and walk into your next appointment with clear questions instead of guesswork.
Last reviewed for medical accuracy: 09/28/2026
Lurasidone is a second-generation (atypical) antipsychotic prescribed for schizophrenia and bipolar depression. Like all medications, it can cause side effects. Knowing what to expect, how to manage symptoms, and when to seek help can make treatment safer and more comfortable.
Most people tolerate lurasidone well, but you may experience:
Most side effects are mild and improve over time. Always report anything that worries you to your prescriber.
Akathisia is a feeling of inner restlessness that can range from mild discomfort to overwhelming urge to move. It’s one of the more common neurological side effects of lurasidone.
Signs You Might Notice
Tips to Manage Restlessness
Never adjust your dose without medical advice.
Lurasidone absorption increases significantly when taken with food. To ensure you’re getting the right dose:
Consistency matters. Pick meals or snacks you can have reliably at dosing times.
Regular check-ups help detect and manage side effects early:
Baseline Assessments
Ongoing Monitoring
Additional Tests
Keeping a simple log of your weight, side effects, and food intake can be helpful for you and your doctor.
Most side effects are mild, but some require prompt attention:
If you experience any life-threatening or serious symptoms, call emergency services or go to the nearest emergency department.
If you’re unsure whether your symptoms are related to lurasidone or need guidance on what to watch for, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.
This information is not a substitute for medical advice. Always:
Your health and safety come first—open communication with your healthcare team is key.
(References)
* Caccia S. Pharmacokinetics and metabolism update for some recent antipsychotics. Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):829-46. doi: 10.1517/17425255.2011.575061. Epub 2011 Apr 8. PMID: 21476873.
* Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. PMID: 29536616; PMCID: PMC5947163.
* Lumateperone (Caplyta) for schizophrenia. Med Lett Drugs Ther. 2020 Jul 27;62(1603):113-116. PMID: 32728011.
* Correll CU, Tocco M, Pikalov A, Hsu J, Goldman R. Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis. Schizophr Res. 2022 Feb;240:205-213. doi: 10.1016/j.schres.2021.12.046. Epub 2022 Jan 12. PMID: 35032906.
* Lumateperone (Caplyta) for bipolar depression. Med Lett Drugs Ther. 2022 Aug 8;64(1656):126-128. PMID: 35921078.
* Carnovale C, Battini V, Santoro C, Riccio MP, Carucci S, Nobile M, Formisano P, Bravaccio C, Zuddas A, Clementi E, Pozzi M, Pisano S. Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents. J Am Acad Child Adolesc Psychiatry. 2024 Mar;63(3):313-335. doi: 10.1016/j.jaac.2023.04.018. Epub 2023 Jun 23. PMID: 37391174.
* Strašilová Z, Turjap M, Juřica J. Therapeutic monitoring of antipsychotics with a focus on lurasidone and its dosing. Ceska Slov Farm. 2023;72(5):203-213. doi: 10.5817/CSF2023-5-203. PMID: 38185643.
* Drugs for bipolar disorder. Med Lett Drugs Ther. 2024 Apr 1;66(1699):49-54. doi: 10.58347/tml.2024.1699a. PMID: 38576143.
* Iloperidone (Fanapt) - a new indication for bipolar disorder. Med Lett Drugs Ther. 2024 Jul 22;66(1707):115-116. doi: 10.58347/tml.2024.1707c. PMID: 39008105.
* Takahashi M, Shelton RC. A novel sequential ketamine and D-cycloserine/lurasidone therapy for bipolar depression with acute suicidal ideation. Expert Opin Investig Drugs. 2026 May;35(5):315-322. doi: 10.1080/13543784.2026.2674645. Epub 2026 May 26. PMID: 42166622.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.